Key points are not available for this paper at this time.
Abstract Vitiligo is a prevalent autoimmune skin disorder that presents as patches of depigmentation. While the disease is typically asymptomatic, the lesions are highly noticeable and can cause substantial psychosocial distress. Depending on the subtype, extent, and activity of the disease, various topical treatments, systemic treatments, phototherapy modalities, and surgical interventions are used to halt disease progression and facilitate repigmentation. However, there is generally a lack of evidence from well-designed, large-scale, controlled trials supporting specific treatment approaches, and recommendations of existing clinical guidelines frequently differ. To address these challenges, the Taiwanese Dermatological Association established an expert committee to develop consensus recommendations to provide clinicians with guidance on the diagnosis, assessment, and management of vitiligo to improve the quality of patient care in Taiwan.
Lan et al. (Wed,) studied this question.